Martingale Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,914
| Closed | -$829K | – | 894 |
|
|
2021
Q4 | $829K | Sell |
8,914
-5,500
| -38% | -$362K | 0.01% | 538 |
|
|
2021
Q3 | $859K | Buy |
14,414
+7,198
| +100% | +$425K | 0.01% | 544 |
|
|
2021
Q2 | $493K | Sell |
7,216
-2,597
| -26% | -$169K | 0.01% | 596 |
|
|
2021
Q1 | $682K | Buy |
9,813
+3,502
| +55% | +$269K | 0.01% | 523 |
|
|
2020
Q4 | $485K | Sell |
6,311
-2,000
| -24% | -$150K | 0.01% | 623 |
|
|
2020
Q3 | $622K | Sell |
8,311
-4,500
| -35% | -$300K | 0.01% | 752 |
|
|
2020
Q2 | $807K | Sell |
12,811
-11,803
| -48% | -$649K | 0.01% | 782 |
|
|
2020
Q1 | $1.03M | Sell |
24,614
-5,101
| -17% | -$234K | 0.01% | 664 |
|
|
2019
Q4 | $1.35M | Buy |
29,715
+3,002
| +11% | +$142K | 0.01% | 700 |
|
|
2019
Q3 | $1.22M | Buy |
26,713
+6,305
| +31% | +$354K | 0.01% | 721 |
|
|
2019
Q2 | $1.2M | Buy |
20,408
+4,504
| +28% | +$233K | 0.01% | 733 |
|
|
2019
Q1 | $713K | Buy |
15,904
+4,600
| +41% | +$211K | 0.01% | 835 |
|
|
2018
Q4 | $441K | Buy |
+11,304
| New | +$444K | 0.01% | 875 |
|
Martingale Asset Management's ARNA Position: Q1 2022 in Review
Martingale Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 8,914 shares — an estimated $829K sold.
Martingale Asset Management first reported a position in ARNA in Q4 2018 and held it in 13 quarters. The position peaked at $1.35M in Q4 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Martingale Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Martingale Asset Management sold 8,914 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $829K.
- Martingale Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2018 and held it in 13 quarters.
- Martingale Asset Management's Arena Pharmaceuticals Inc position peaked at $1.35M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Martingale Asset Management's 13F filing for Q1 2022, filed 12 May 2022.